Aquestive Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 http://www.monosolrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics Inc

Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock - Dec 13th, 2019 1:00 am
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint - Dec 11th, 2019 12:21 pm
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock - Dec 10th, 2019 9:01 pm
Top Ranked Momentum Stocks to Buy for December 9th - Dec 9th, 2019 3:04 pm
Aquestive Therapeutics to Host Investor & Analyst Libervant™ (diazepam) Buccal Film Update Forum at American Epilepsy Society 2019 Annual Meeting - Dec 4th, 2019 1:30 pm
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial - Dec 3rd, 2019 12:59 pm
Aquestive Therapeutics Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Libervant™ (diazepam) Buccal Film for Management of Seizure Clusters - Dec 2nd, 2019 12:30 pm
These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush - Nov 29th, 2019 3:29 pm
A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole - Nov 26th, 2019 9:05 pm
Aquestive Therapeutics Announces Poster Presentations of Data on Libervant™ (diazepam) Buccal Film at American Epilepsy Society 2019 Annual Meeting - Nov 26th, 2019 4:27 pm
Company News For Nov 26, 2019 - Nov 26th, 2019 4:07 pm
Aquestive shares jump on FDA approval - Nov 25th, 2019 1:56 pm
Aquestive Therapeutics Receives FDA Approval for Exservan™ (riluzole) Oral Film - Nov 25th, 2019 1:00 pm
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More - Nov 24th, 2019 9:19 pm
REFILE-FDA approves Aquestive's ALS treatment - Nov 22nd, 2019 9:42 pm
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks - Nov 14th, 2019 6:31 pm
Aquestive Therapeutics Licenses Riluzole Oral Film to Zambon for Development and Commercialization in the EU for Patients with ALS - Nov 13th, 2019 1:30 pm
All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy - Nov 11th, 2019 2:00 pm
Company News for Nov 7, 2019 - Nov 7th, 2019 2:42 pm
Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates - Nov 5th, 2019 11:35 pm